171 related articles for article (PubMed ID: 34365135)
1. Repeated intra-articular administration of equine allogeneic peripheral blood-derived mesenchymal stem cells does not induce a cellular and humoral immune response in horses.
Van Hecke L; Magri C; Duchateau L; Beerts C; Geburek F; Suls M; Da Dalt L; Patruno M; Saunders J; Broeckx SY; Depuydt E; Spaas JH
Vet Immunol Immunopathol; 2021 Sep; 239():110306. PubMed ID: 34365135
[TBL] [Abstract][Full Text] [Related]
2. Cellular and Humoral Immunogenicity Investigation of Single and Repeated Allogeneic Tenogenic Primed Mesenchymal Stem Cell Treatments in Horses Suffering From Tendon Injuries.
Depuydt E; Broeckx SY; Chiers K; Patruno M; Da Dalt L; Duchateau L; Saunders J; Pille F; Martens A; Van Hecke L; Spaas JH
Front Vet Sci; 2021; 8():789293. PubMed ID: 35281431
[TBL] [Abstract][Full Text] [Related]
3. Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis.
Colbath AC; Dow SW; Hopkins LS; Phillips JN; McIlwraith CW; Goodrich LR
Equine Vet J; 2020 Jul; 52(4):601-612. PubMed ID: 31821594
[TBL] [Abstract][Full Text] [Related]
4. Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model.
Joswig AJ; Mitchell A; Cummings KJ; Levine GJ; Gregory CA; Smith R; Watts AE
Stem Cell Res Ther; 2017 Feb; 8(1):42. PubMed ID: 28241885
[TBL] [Abstract][Full Text] [Related]
5. Production of Cytotoxic Antibodies After Intra-Articular Injection of Allogeneic Synovial Membrane Mesenchymal Stem Cells With and Without LPS Administration.
Rosa GDS; Krieck AMT; Padula ET; Stievani FC; Rossi MC; Pfeifer JPH; Basso RM; Braz AMM; Golim MA; Alves ALG
Front Immunol; 2022; 13():871216. PubMed ID: 35572507
[TBL] [Abstract][Full Text] [Related]
6. Equine allogeneic chondrogenic induced mesenchymal stem cells: A GCP target animal safety and biodistribution study.
Broeckx SY; Spaas JH; Chiers K; Duchateau L; Van Hecke L; Van Brantegem L; Dumoulin M; Martens AM; Pille F
Res Vet Sci; 2018 Apr; 117():246-254. PubMed ID: 29329028
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
Vet Immunol Immunopathol; 2013 Nov; 156(1-2):99-106. PubMed ID: 24094688
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory response to the administration of mesenchymal stem cells in an equine experimental model: effect of autologous, and single and repeat doses of pooled allogeneic cells in healthy joints.
Ardanaz N; Vázquez FJ; Romero A; Remacha AR; Barrachina L; Sanz A; Ranera B; Vitoria A; Albareda J; Prades M; Zaragoza P; Martín-Burriel I; Rodellar C
BMC Vet Res; 2016 Mar; 12():65. PubMed ID: 27029614
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses.
Owens SD; Kol A; Walker NJ; Borjesson DL
Stem Cells Int; 2016; 2016():5830103. PubMed ID: 27648075
[TBL] [Abstract][Full Text] [Related]
10. Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses.
Broeckx SY; Seys B; Suls M; Vandenberghe A; Mariën T; Adriaensen E; Declercq J; Van Hecke L; Braun G; Hellmann K; Spaas JH
Stem Cells Dev; 2019 Mar; 28(6):410-422. PubMed ID: 30623737
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic vs. autologous intra-articular mesenchymal stem cell injection within normal horses: Clinical and cytological comparisons suggest safety.
Colbath AC; Dow SW; Hopkins LS; Phillips JN; McIlwraith CW; Goodrich LR
Equine Vet J; 2020 Jan; 52(1):144-151. PubMed ID: 31120574
[TBL] [Abstract][Full Text] [Related]
12. Allo-antibody production after intraarticular administration of mesenchymal stem cells (MSCs) in an equine osteoarthritis model: effect of repeated administration, MSC inflammatory stimulation, and equine leukocyte antigen (ELA) compatibility.
Barrachina L; Cequier A; Romero A; Vitoria A; Zaragoza P; Vázquez FJ; Rodellar C
Stem Cell Res Ther; 2020 Feb; 11(1):52. PubMed ID: 32028995
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells for treatment of musculoskeletal disease in horses: Relative merits of allogeneic versus autologous stem cells.
Colbath AC; Dow SW; McIlwraith CW; Goodrich LR
Equine Vet J; 2020 Sep; 52(5):654-663. PubMed ID: 31971273
[TBL] [Abstract][Full Text] [Related]
14. Cross-matching of allogeneic mesenchymal stromal cells eliminates recipient immune targeting.
Rowland AL; Miller D; Berglund A; Schnabel LV; Levine GJ; Antczak DF; Watts AE
Stem Cells Transl Med; 2021 May; 10(5):694-710. PubMed ID: 33369287
[TBL] [Abstract][Full Text] [Related]
15. The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double-blinded, placebo-controlled proof-of-concept study.
Broeckx SY; Martens AM; Bertone AL; Van Brantegem L; Duchateau L; Van Hecke L; Dumoulin M; Oosterlinck M; Chiers K; Hussein H; Pille F; Spaas JH
Equine Vet J; 2019 Nov; 51(6):787-794. PubMed ID: 30815897
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunomodulatory properties of equine peripheral blood-derived mesenchymal stem cells in healthy cats.
Debosschere Y; Depuydt E; Pauwelyn G; Beerts C; Van Hecke L; Verhaert L; Duchateau L; Saunders J; Tack L; Spaas JH
Vet Immunol Immunopathol; 2020 Sep; 227():110083. PubMed ID: 32563854
[TBL] [Abstract][Full Text] [Related]
17. Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.
Kol A; Wood JA; Carrade Holt DD; Gillette JA; Bohannon-Worsley LK; Puchalski SM; Walker NJ; Clark KC; Watson JL; Borjesson DL
Stem Cell Res Ther; 2015 Apr; 6(1):73. PubMed ID: 25888916
[TBL] [Abstract][Full Text] [Related]
18. Intra-Articular Injection of 2 Different Dosages of Autologous and Allogeneic Bone Marrow- and Umbilical Cord-Derived Mesenchymal Stem Cells Triggers a Variable Inflammatory Response of the Fetlock Joint on 12 Sound Experimental Horses.
Bertoni L; Branly T; Jacquet S; Desancé M; Desquilbet L; Rivory P; Hartmann DJ; Denoix JM; Audigié F; Galéra P; Demoor M
Stem Cells Int; 2019; 2019():9431894. PubMed ID: 31191689
[TBL] [Abstract][Full Text] [Related]
19. Immune response to allogeneic equine mesenchymal stromal cells.
Kamm JL; Riley CB; Parlane NA; Gee EK; McIlwraith CW
Stem Cell Res Ther; 2021 Nov; 12(1):570. PubMed ID: 34772445
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses.
Carrade DD; Owens SD; Galuppo LD; Vidal MA; Ferraro GL; Librach F; Buerchler S; Friedman MS; Walker NJ; Borjesson DL
Cytotherapy; 2011 Apr; 13(4):419-30. PubMed ID: 21105841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
